Funded Tech Companies
Notch Therapeutics
Wondering who provided funding to Notch Therapeutics? Allogene Therapeutics, CCRM and EcoR1 Capital Management joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Notch Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
40 King St. West 2100
Toronto ON, M5H 3C2
Canada
Toronto ON, M5H 3C2
Canada
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Notch is developing renewable, stem cell-derived immunotherapies, with an initial focus on cancer. We believe that cell therapies can bring value to patients and healthcare systems by being safe, effective, and accessible.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/17/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Main
Chief Financial Officer
Kamran Alam
Chief Scientific Officer
Peter Zandstra
Controller
Zain Qureshi
Vice President
Chris Bond
Vice President
Emily Titus
VP - Bus. Development
Gregory Block
VP - Engineering
Steven Woodside
VP - Finance
Bernard Lam
VP - Manufacturing
Elizabeth Csaszar
VP - Operations
Timothy Key
VP - R & D
Shreya Shukla
Company Investors
- Allogene Therapeutics
- CCRM
- EcoR1 Capital Management
- Samsara BioCapital
- Amplitude Ventures
- Lumira Capital
- Casdin Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs